Cite Filings / DFTX / 0001104659-24-076002

Feed Companies Filings Check

Sign in

S-3ASR

Registration Statement

Definium Therapeutics, Inc. Filed 2024-06-28 Acc 0001104659-24-076002

Documents 1

S-3ASR Registration Statement , tm2416298-1_s3asr.htm

Around this filing

2024-06-28 8-K Material agreement · Other events
2024-06-28 S-3ASR Registration Statement
2024-06-28 S-8 Securities Offered to Employees in Benefit Plans
2024-06-25 144 Sale of Securities
2024-06-25 4 Chief Legal Officer sold 17,854 shares at $7.22 ($128,906)
2024-06-25 4 Chief Medical Officer sold 6,925 shares at $7.22 ($49,999)
2024-06-25 4 Chief Executive Officer sold 15,659 shares at $7.22 ($113,058)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2416298-1_s3asr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…